Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Human coagulation factor VIIIa (factor VIIIa) plays a critical role in the blood coagulation cascade.
• Understanding the kinetics of factor VIIIa decay is essential for comprehending hemostasis and developing effective anticoagulant or procoagulant therapies.

Purpose of the Study:

• To investigate the decay kinetics of human factor VIIIa activity.
• To determine the influence of different activators (thrombin and factor Xa) on factor VIIIa decay rates.
• To explore the role of von Willebrand factor and factor IXa in factor VIIIa stability and activity.

Main Methods:

• Kinetic analysis of factor VIIIa decay under controlled conditions to avoid proteolytic feedback.
• Comparative studies of factor VIII-von Willebrand factor complex and factor VIII alone.
• Assessment of decay rates with varying concentrations of factor IXa.

Main Results:

• Factor VIIIa decay rates are dependent on the activating enzyme; thrombin-activated factor VIIIa decays faster than factor Xa-activated factor VIIIa.
• The presence of von Willebrand factor does not significantly alter the decay rate of factor VIIIa.
• Factor IXa influences factor VIIIa decay in a concentration-dependent manner, with linear relationships observed between reciprocal decay rates and factor IXa levels.

Conclusions:

• The activator significantly impacts factor VIIIa decay kinetics.
• Differences in decay rates and cofactor activity between factor VIIIa species likely stem from a common cause.
• A kinetic model incorporating these findings can elucidate factor VIII activation and decay processes.